This inventor holds 2 USPTO granted patents and 6 published patent applications. Top assignees: Akifumi Matsuyama, Other. Active years: 2016-2017.
Location History:
- Suita, JP (2016)
- Chiba, JP (2017)
Company Filing History:
Years Active: 2016-2017
Title: Hiroshi Komoda: Innovator in Adipose Tissue Research
Introduction
Hiroshi Komoda is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of biotechnology, particularly in the area of adipose tissue-derived cells. With a total of 2 patents, his work focuses on innovative methods for cell production and differentiation.
Latest Patents
Hiroshi Komoda's latest patents include a groundbreaking method for producing multipotent progenitor cells derived from adipose tissue. This patent discloses a cell mass containing these progenitor cells and outlines a method that involves removing erythrocytes from an adipose-tissue-derived cell mass. The process further includes isolating the desired multipotent progenitor cells from the preadipose-tissue-derived mass. Another significant patent involves a method for obtaining pancreatic endocrine cells from adipose tissue-origin cells. This method emphasizes the cultivation of these cells and their potential applications in treating diseases related to pancreatic endocrine cell hypofunction.
Career Highlights
Throughout his career, Hiroshi Komoda has worked on various innovative projects that have advanced the understanding of adipose tissue and its applications in medicine. His research has opened new avenues for therapeutic interventions, particularly in regenerative medicine.
Collaborations
Hiroshi has collaborated with notable individuals in his field, including Yoshiki Sawa and Akifumi Matsuyama. These collaborations have contributed to the development of his patents and the advancement of research in adipose tissue-derived cells.
Conclusion
Hiroshi Komoda's contributions to the field of biotechnology through his patents and research are noteworthy. His innovative methods for working with adipose tissue have the potential to impact medical treatments significantly.